Keyphrases
Netherlands
100%
Survival Disparities
46%
Older Adults
46%
Pediatric Renal Tumors
46%
Population-based Study
26%
Non-Hodgkin Lymphoma
26%
Advanced Disease
26%
Hazard Ratio
23%
Large Cohort Study
23%
Young Adolescents
23%
Young Cancer Patients
23%
Dutch Population
23%
Adherence to the Mediterranean Diet
23%
Mediterranean Diet Adherence
23%
Tumor Volume
23%
COVID-19
23%
Observed Survival
23%
Advanced Stage
23%
Group Studies
23%
Cancer Incidence
23%
Brazil
23%
Acute Myeloid Leukemia
23%
Tumor Research
23%
COVID-19 Pandemic Impact
23%
Wilms Tumor
23%
Pandemic Impact
23%
COVID-19 Pandemic
23%
Renal Tumor
23%
Improved Survival
23%
5-year Survival
21%
Cancer Risk
16%
Multivariable
16%
Second Cancer Risk
15%
Cancer Registry
13%
Renal Malignancy
11%
Delay in Referral
11%
Population Mobility
11%
Referral Time
11%
National Lockdown
11%
COVID-19 Restrictions
11%
Mobility Rate
11%
Pandemic Severity
11%
Impact on Society
11%
Lockdown Period
11%
Immobilization
11%
Disease Diagnosis
11%
Pediatric Cancer
11%
Intensive Care Admission
11%
Disease Management
11%
New Diagnosis
11%
Tumor
11%
Newly Diagnosed Patients
11%
Europe
11%
Specialized Center
11%
Disease Pattern
11%
Patients Included
11%
Lockdown
11%
Tumor Characteristics
11%
Non-communicable Diseases
11%
Tumor Patients
11%
First Month
11%
Clinical Outcomes
11%
Average Annual Percentage Change
10%
Alcohol
9%
Mediterranean Diet Score
9%
Confidence Interval
9%
Pediatric Patients
8%
Rhabdoid Tumor
7%
Trends in Incidence
7%
Risk Statistics
7%
Excess Cancer Risk
7%
Risk Overestimation
7%
Testicular Cancer Survivors
7%
Parametric Survival Model
7%
Time Trends
7%
Trends in Survival
7%
Cancer Subgroups
6%
Ratio Estimate
6%
Statistical Significance
6%
Mortality Rate
6%
Cancer Mortality
6%
Survival Improvement
5%
All Ages
5%
Early Mortality
5%
Medicine and Dentistry
Adolescence
96%
Kidney Tumour
46%
Pediatrics
46%
Malignant Neoplasm
33%
Non-Hodgkin Lymphoma
30%
Neoplasm
26%
Disease
26%
COVID-19
23%
Wilms' Tumor
23%
Cancer in Adolescents
23%
Overall Survival
23%
Acute Myeloid Leukemia
23%
Second Cancer
23%
Cancer Risk
23%
Hazard Ratio
20%
Cancer Registry
18%
Cancer
17%
Diagnosis
16%
Ganglioneuroblastoma
15%
Mortality Rate
15%
Cancer Mortality
15%
Cancer in Young Adults
9%
Cumulative Incidence
9%
Population
9%
Pediatrics Patient
9%
Malignant Rhabdoid Tumour
9%
Patient Referral
9%
Osteosarcoma
7%
Survival Rate
7%
Cancer Survival
7%
Central Nervous System Tumor
7%
Ewing Sarcoma
7%
Survival Analysis
7%
Proteus Syndrome
6%
Relative Survival
5%